Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Portage Biotech Inc acquires majority interest in Biohaven Pharmaceutical Holding Company Limited


Monday, 6 Jan 2014 05:00pm EST 

Portage Biotech Inc:Says it has acquired about 54 percent equity in Biohaven Pharmaceutical Holding Company Limited, for C$3.5 million, payable as C$1.75 million upfront and the balance in three installments over the next eleven months.Says Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. 

Company Quote

0.089
-0.0060 -5.82%
19 Dec 2014